Geneva, March 17, 2011: Ares Life Sciences, a healthcare-focused investment
firm, announced that it holds as of today 73.18% of the capital and voting
rights of Stallergenes.
In November 2010, Ares Life Sciences acquired Wendel’s equity stake in
Stallergenes, representing 46% of the company’s share capital and voting
rights, at a price of €59.00 per share. Following this transaction and in
compliance with the existing regulation, Ares Life Sciences launched a
mandatory takeover offer for all remaining outstanding shares of Stallergenes
at the same price of €59.00 per share in cash. The offering period closed on
Friday March 11, 2011.
About Ares Life Sciences
Ares Life Sciences is a healthcare-focused investment firm, whose financial
backer is the Bertarelli family. Its strategy is to focus on key life sciences
sectors, mainly: pharmaceuticals and biotechnology, medical diagnostics,
and medical technology (MedTech). Ares Life Sciences has a long-term view
on investments and a core element of its investment strategy is to make
available to its portfolio companies the collective experience and network of
its team in the healthcare sector. Ares Life Sciences’ portfolio currently
includes investments in, Euromedic, Esaote, Santhera and Broncus.
Stallergenes is a European biopharmaceutical laboratory specialising in
treatments by immunotherapy for the treatment of allergy-related respiratory
conditions, such as rhino conjunctivitis, rhinitis and allergic asthma. A pioneer
and a leader in immunotherapy treatments by sublingual administration,
Stallergenes dedicates more than 20% of its gross sales to its research and
development activities, which are primarily directed at developing a new
therapeutic range: immunotherapy treatments by sublingual tablets.
Stallergenes achieved 2010 sales of €216 million, with over 500,000 patients
treated with Stallergenes products.
Contact persons :
Christophe Lamps - Dynamics Group
Rue des Caroubiers 21, Geneva, Switzerland
Tel:+41 22 308 62 20 Mob: +41 79 476 26 87 Fax: +41 22 308 62 36
Agnes Catineau/Marie-Laurence Bouchon
Tel: +33 1 53 96 83 83
Tel: +44 20 7396 5312
Paco Latorre - Ares Life Sciences
Avenue Guiseppe Motta 31-33, CH- 1211 Geneva 20, Switzerland
Tel: +41 79 5716207